- Author:
An-Qi LIU
1
;
Lei ZHOU
1
;
Yong-Hui LI
1
;
Yu JING
1
;
Shu-Hong WANG
1
;
Jun-Hui MEI
1
;
Li-Ping DOU
1
;
Li-Li WANG
1
;
Li YU
2
Author Information
- Publication Type:Journal Article
- MeSH: Anemia; pathology; Autoimmune Diseases; pathology; Chromosome Aberrations; Hemoglobins; analysis; Humans; Immunophenotyping; Leukemia, Large Granular Lymphocytic; diagnosis; pathology; Middle Aged; Retrospective Studies; Spleen; pathology
- From: Journal of Experimental Hematology 2016;24(3):693-697
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo analyze the clinical manifestations and laboratory features of patients with T large granular lymphocytic leukemia (T-LGLL), so as to improve the understanding of this disease.
METHODSThe clinical data of 10 patients with T-LGLL in General Hospital of Chinese PLA from October 2015 to March 2010 were analyzed retrospectively.
RESULTSTheir median age at diagnosis was 51 years old. 9/10 (90%) patients showed symptoms of anemia, with a median Hb level of 82.5 g/L, 5/10 (50%) patients combined with autoimmune disorders and with a median Hb level of 77 g/L. 7/10 (70%) patients had splenomegaly, 2/10 (20%) patients had complex karyotype, 2/10 (20%) patients had gene mutations, the median age of 4 patients with complex karyotype and gene mutation was 49 years old, all of them suffered from splenomegaly. The immunophenotype of 6/10 patients was CD3+ CD4- CD8+ and that of 2/10 patients (20%) was CD3+ CD4- CD8-, that of another 2/10 (20%) was CD3+ CD4+ CD8-, the clinical features between different types of immunization were not statistically different.
CONCLUSIONT-LGLL patients often are old men, combined with anemia and splenomegaly, often associated with autoimmune diseases; the patients with complex karyotype and gene mutation are younger and they are more with hepatosplenomegaly; the guide role of different immunotypes for clinical strategy is no significant.